Identification of subjects being susceptible to anti-angiogenesis therapy
US9983213B2 · kind B2 · utility
0Cited by
6References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 20, 2011 |
| Grant date | May 29, 2018 |
| Priority date | — |
| Expiry date | Apr 24, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to a method for identifying a subject being susceptible to anti-angiogenesis therapy based in determining the amount of a cardiac troponin in a sample of the subject and comparing the amount to a suitable reference amount. Also encompassed by the present invention are kits and devices adapted to carry out the method of the present invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.